Neural Therapeutics Inc. (CSE:NURL)

Canada flag Canada · Delayed Price · Currency is CAD
0.0300
0.00 (0.00%)
At close: Mar 28, 2025
0.00%
Market Cap 2.66M
Revenue (ttm) n/a
Net Income (ttm) -608.78K
Shares Out 88.70M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 23,447
Average Volume 117,987
Open 0.0300
Previous Close 0.0300
Day's Range 0.0300 - 0.0300
52-Week Range 0.0200 - 0.0350
Beta n/a
RSI n/a
Earnings Date n/a

About Neural Therapeutics

Neural Therapeutics Inc., a drug discovery company, focuses on plant-based active substances. It focuses on San Pedro, a cactus containing mescaline and delivers over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat serious mental ailments. Neural Therapeutics Inc. was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in November 2021. The company was incorporated in 2020 and is headquartered in Toronto, Canada. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2020
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol NURL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.